Results 211 to 220 of about 218,306 (297)

Predictive Biomarkers in Metastatic Colorectal Cancer Patients Treated With Bevacizumab: A Turkish Oncology Group (TOG) Study

open access: yesInternational Journal of Cancer, EarlyView.
Bevacizumab added to systemic chemotherapy remains a cornerstone of metastatic colorectal cancer treatment, but its effectiveness is variable. Tumors can bypass the VEGF blockade by activating other pro‐angiogenic pathways, hampering the identification of predictive biomarkers.
Büsra Akay Hacan   +9 more
wiley   +1 more source

Total Neoadjuvant Treatment for Esophageal Adenocarcinoma With Oligometastases: TNT‐OES‐1 Trial

open access: yesInternational Journal of Cancer, EarlyView.
Total neoadjuvant therapy could combine the potentially strong systemic effect of FLOT chemotherapy with the good locoregional control of CROSS chemoradiotherapy. While total neoadjuvant therapy is increasingly used in rectal cancer, its potential in gastroesophageal cancer remains largely unexplored.
Charlène J. van der Zijden   +12 more
wiley   +1 more source

Correction to: Sonological predictors of complications of percutaneous renal biopsy-a prospective observational study. [PDF]

open access: yesIr J Med Sci
Bhattacharya S   +6 more
europepmc   +1 more source

Can the Parallel or Tandem Combination of Questionnaire‐Based Risk Assessment and Fecal Immunochemical Test Improve the Efficiency of Colorectal Cancer Screening?

open access: yesInternational Journal of Cancer, EarlyView.
Colorectal cancer screening reduces disease burden, but the comparative performance of screening strategies remains unclear. This population‐based study shows that the tandem strategy (positive results from both questionnaire‐based risk assessment and fecal immunochemical testing) substantially improved the detection rates of colorectal cancer and ...
Ruyue Liu   +5 more
wiley   +1 more source

Epigenetic Regulation in the Pathogenesis of Renal Inflammation: Insights and Therapeutic Potentials

open access: yesiNew Medicine, EarlyView.
ABSTRACT Renal inflammation is a common pathological process in various kidney diseases, often initiated by factors such as toxins, ischemia, or autoimmune reactions. This inflammatory response can result in structural damage and a rapid decline in renal function.
Yu‐Hang Dong   +5 more
wiley   +1 more source

Transjugular Random Renal Biopsy: How We Do It. [PDF]

open access: yesSemin Intervent Radiol
Laney Iv DF, Ferral H.
europepmc   +1 more source

Multi‐omics biomarkers for intestinal infection and inflammation in inflammatory bowel disease: Current evidence, translational challenges, and diagnostic opportunities

open access: yesInterdisciplinary Medicine, EarlyView.
Prospective multi‐site cohorts, multi‐omics profiling, and computational analysis may help identify biomarker patterns across clinical settings in IBD and superimposed infections. With further mechanistic and clinical validation, these signals could support the development of practical multi‐analyte tools for more precise diagnosis and management ...
Ziyu Yang   +7 more
wiley   +1 more source

Sonological predictors of complications of percutaneous renal biopsy-a prospective observational study. [PDF]

open access: yesIr J Med Sci
Bhattacharya S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy